Invited Speakers

Julio Aguirre-Ghiso, PhD, Assistant Professor, Center for Excellence in Cancer Genomics,  Structural and Cell Biology Department of Biomedical Sciences, School of Public Health, University at Albany, State University of New York, USA

Catherine Alix - Panabières, PhD, Medical Center of Montpellier, Lapeyronie Hospital, Immuno-Virology Dept., Montpellier, France 

Gert Attard, Gert  Attard, MD Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom

Phil Bernard, MD, Medical Director of the Solid Tumor Molecular Diagnostics Laboratory, ARUP. Associate Professor of Pathology, University of Utah, School of Medicine, USA

George A. Calin, MD, PhD, Associate Professor, Department of Experimental Therapeutics , The University of Texas,  M. D. Anderson Cancer Center, Houston, Texas, USA

Ann F. Chambers, PhD, Canada Research Chair in Oncology, Professor, Department of Oncology, Schulich School of Medicine & Dentistry, University of Western Ontario, London Regional Cancer Program, London, Canada

Michael F. Clarke, MD, PhD, Professor, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA, USA

Richard K.  Cote, MD, Professor, Director, Genitourinary Cancer Program, Keck School of Medicine, Los Angeles, CA, USA

Lisa  M. Coussens, PhD, Professor of Pathology,  Cancer Research Institute and Anatomic Pathology, University of California San Franscisco, USA

Massimo Cristofanilli, MD, Associate Professor of Medicine, Department of Breast Medical Oncology  University of Texas, MD Anderson Cancer Center, Houston, TX, USA 

Tanja Fehm, MD, Professor,  Department of Gynaecology and Obstetrics, University of Tübingen, Tübingen, Germany

Dave S.B. Hoon, PhD, Director, Department Molecular Oncology , John Wayne cancer Institute, Santa Monica, CA, USA

Michail Ignatiadis, MD, PhD, Assist. Professor, Jules Bordet Institute, Brussels, Belgium

J. Wolfgang Janni, MD, Obstetrics and Gynecology Clinic and Polyclinic of Ludwig Maximilian University, Klinikum Innenstadt, München, Germany  

Hasan Korkaya, DVM., PhD, Int Med-Hematology/Oncology, University of Michigan, Ann Arbor, USA 

Peter Kuhn, PhD, The Scripps-PARC Institute for Advanced Biomedical Science, Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA

Evi S. Lianidou, PhD, Assoc. Professor, Dept of Chemistry, National and Kapodistrian University of Athens, Greece

Dimitris Mavroudis, MD, PhD, Assoc. Professor, Medical Oncology, University of Crete, Greece

Bjorn Naume, MD, Department of Oncology, Radium Hospital, Oslo, Norway

Klaus Pantel, MD, PhD, Professor, Institute of Tumor Biology , Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Jean-Yves Pierga, MD, Department of Medical Oncology, Institute Curie, Paris, France 

Bernhard Polzer, MD, Division of Oncogenomics, University of Regensburg, Regensburg, Germany 

Howard I. Scher, MD, Chief, Genitourinary Oncology Service, D. Wayne Calloway Chair in Urologic Oncology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan –Kettering Cancer Center, New York, USA

Christos Sotiriou, MD, PhD, Head of Functional Genomics & Translational Research Unit, Jules Bordet Institute, Brussels, Belgium

Patricia S. Steeg, PhD, Head, Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute. NCI, Bethesda, USA

Leon W.M.M. Terstappen, MD, PhD, Professor, University of Twente, Faculty of Sciences and Technology, The Netherlands

Jean Paul Thiery, PhD, Professor, Deputy Director,  Institute of Molecular and Cell Biology, Chief Scientific Officer Experimental Therapeutics Centre,  Biopolis, Singapore

Andreas Trumpp, PhD, Professor and Head of the Department for Stem Cell and Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Philip Tsichlis, MD, Professor of Hematology and Oncology, Director, Molecular Oncology Research Institute, Tufts University School of Medicine, Boston, Massachusetts, USA

Jonathan Uhr, MD, Professor, Cancer Immunobiology Center, UT Southwestern Medical Center Dallas, Texas, USA

Danny R. Welch, PhD, Professor of Pathology, University of Alabama, Birmingham, AL, President, Metastasis Research Society, USA 

Carl T. Wittwer, MD, PhD, Professor, Department of Pathology, Univ of Utah;, Adjunct Professor, Biomedical Engineering, University of Utah, School of Medicine, USA